Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Nearing Retirement? These Stocks Will Pay You For Life


While government programs help retirees replace some of their income once they stop working, these initiatives aren't meant to fund all of people's expenses in their golden years. That's why many retirees seek additional income. One place to look is the stock market. Investing in reliable dividend stocks can be a great source of steady passive income, but only if the stocks in question have the tools to distribute growing payouts for a while.

Let's look at two companies that can do that: (NYSE: ABBV) and Gilead Sciences (NASDAQ: GILD).

AbbVie is well-known among dividend investors thanks to its solid business, strong prospects, and excellent dividend profile. Let's start with the company's business. AbbVie markets a range of drugs across several therapeutic areas, although its top field of expertise is arguably immunology. The company recently lost U.S. patent protection for its blockbuster therapy Humira. That's why AbbVie's sales have been declining and why it has performed poorly on the stock market since January.

Continue reading


Source Fool.com

AbbVie Inc. Aktie

173,86 €
-1,13 %
Heute verliert die AbbVie Inc. Aktie an Boden, ein Rückgang von -1,13 %.
Einzigartige Zustimmung für AbbVie Inc. mit ausschließlich Buy-Einschätzungen.
Ein positives Kurspotenzial für AbbVie Inc. ist gegeben, mit einem Kursziel von 180 € über dem aktuellen Kurs von 173.86 €.
Like: 0
Teilen

Kommentare